Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by CancerSlayeron Jun 04, 2022 10:52pm
335 Views
Post# 34732196

RE:When to Sell

RE:When to Sell

Camphikefish wrote: Perhaps it is a sensitive subject however, curious to see what others think. As I study the charts of other past hopefuls like sesen and Ibrx, there came a point in time when if you sold you made loads of money or held waiting for a higher price and eventually lost. I know it is an obvious phenomenon to buy low and sell high but there must be an art to it. Do most of you believe we will get to $10.00? I see where others might be happy with $5.00 and yet others think $50.00 and beyond is the number. What does your gut tell you the Theralase price per share will rise to? I will start by saying I believe somewhere between $15 & $ 20 based on all I've read and the rationale you all have provided. We all are wondering the same thing. I am simply asking for fun and curiosity what you folks think we'll get to. I probably do not have the nerve for waiting for much of anything beyond $12.00 as a threshold because of my age and goals for the remainder of this precious life. I can live with losing out on upside profit however, I can not live with a rise and steep drop which might never return upwards. 

 

I look at it from a risk/reward perspective.  Imo, an FDA approval for the current indication would be the final step in the validation of this science (the successful transition from bench to bedside).  This achievement would essentially remove all risk for me, & moving forward it would be all about degree of reward.  A pure cash deal would give closure to some, but certainly this ACT's potential reward would keep me in the game.  

The only unlikely downside risk that I see would be if an acquirer were to hamstring our tech (disuse or at least temporarily place it on the back burner) for the sake of their own invested therapies/revenue streams.  That's why I would negotiate in any partnership/buyout not only a hefty price tag, but also a reasonable timeline for intended use/marketing. 

Knowing the unlimited rewards & value appreciation post approval (considering both cancer & infection indications), I'm not selling a single share until my retirement piggy bank demands it.  

<< Previous
Bullboard Posts
Next >>